Navidea Biopharmaceuticals - 33 Year Stock Price History | NAVB
Historical daily share price chart and data for Navidea Biopharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Navidea Biopharmaceuticals as of July 07, 2025 is 0.00.
- The all-time high Navidea Biopharmaceuticals stock closing price was 440.00 on March 22, 1996.
- The Navidea Biopharmaceuticals 52-week high stock price is 0.13, which is % above the current share price.
- The Navidea Biopharmaceuticals 52-week low stock price is 0.00, which is % below the current share price.
- The average Navidea Biopharmaceuticals stock price for the last 52 weeks is 0.00.
| Navidea Biopharmaceuticals Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.0007 | 0.0001 | 0.0100 | 0.0001 | 0.0002 | 100.00% |
| 2024 | 0.0170 | 0.0540 | 0.0642 | 0.0001 | 0.0001 | -99.82% |
| 2023 | 0.1495 | 0.2700 | 0.3428 | 0.0300 | 0.0552 | -73.71% |
| 2022 | 0.6179 | 1.2000 | 1.2000 | 0.1770 | 0.2100 | -79.00% |
| 2021 | 1.7931 | 2.2700 | 2.9000 | 1.0000 | 1.0000 | -53.49% |
| 2020 | 2.2506 | 1.2900 | 4.9500 | 0.7000 | 2.1500 | 70.63% |
| 2019 | 1.5742 | 2.2931 | 3.6000 | 0.5000 | 1.2600 | -38.63% |
| 2018 | 5.1365 | 7.7800 | 8.1980 | 2.0531 | 2.0531 | -71.37% |
| 2017 | 9.5384 | 12.9260 | 15.4620 | 6.8740 | 7.1700 | -43.76% |
| 2016 | 16.8253 | 25.8000 | 30.0000 | 6.0000 | 12.7500 | -52.07% |
| 2015 | 33.8508 | 38.6000 | 48.2000 | 24.8000 | 26.6000 | -29.63% |
| 2014 | 30.9714 | 40.0000 | 41.2000 | 20.4000 | 37.8000 | -8.70% |
| 2013 | 51.8183 | 57.6000 | 68.2000 | 28.0000 | 41.4000 | -26.86% |
| 2012 | 62.1328 | 54.8000 | 93.6000 | 43.8000 | 56.6000 | 8.02% |
| 2011 | 65.4746 | 42.4000 | 109.6000 | 39.0000 | 52.4000 | 27.18% |
| 2010 | 36.5064 | 23.4000 | 43.4000 | 23.4000 | 41.2000 | 68.85% |
| 2009 | 18.5474 | 11.2200 | 28.0000 | 9.0000 | 24.4000 | 114.04% |
| 2008 | 10.6386 | 6.4000 | 16.8000 | 6.4000 | 11.4000 | 99.30% |
| 2007 | 5.3338 | 5.0000 | 9.8000 | 3.8000 | 5.7200 | 19.17% |
| 2006 | 5.5200 | 5.0000 | 7.2000 | 4.6000 | 4.8000 | -2.04% |
| 2005 | 7.5109 | 12.0000 | 13.8000 | 4.9000 | 4.9000 | -58.12% |
| 2004 | 10.2239 | 6.4000 | 20.0000 | 5.8000 | 11.7000 | 88.71% |
| 2003 | 4.0536 | 2.6000 | 9.5000 | 2.0000 | 6.2000 | 138.46% |
| 2002 | 5.2543 | 8.4000 | 10.0000 | 1.5000 | 2.6000 | -69.05% |
| 2001 | 10.2732 | 8.1250 | 18.4000 | 7.0000 | 8.4000 | 0.00% |
| 2000 | 17.5448 | 9.0000 | 60.0000 | 7.5000 | 8.4000 | -4.00% |
| 1999 | 14.4324 | 17.5000 | 36.2500 | 6.2000 | 8.7500 | -39.13% |
| 1998 | 59.1220 | 127.5000 | 127.5000 | 10.0000 | 14.3750 | -88.02% |
| 1997 | 261.0524 | 302.5000 | 357.5000 | 120.0000 | 120.0000 | -60.98% |
| 1996 | 327.7153 | 315.0000 | 440.0000 | 215.0000 | 307.5000 | -4.65% |
| 1995 | 164.8239 | 30.0000 | 360.0000 | 30.0000 | 322.5000 | 975.00% |
| 1994 | 88.5800 | 123.7500 | 145.0000 | 23.7500 | 30.0000 | -76.00% |
| 1993 | 121.7959 | 122.5000 | 155.0000 | 105.0000 | 125.0000 | 4.17% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $195.148B | 85.47 |
| Thermo Fisher Scientific (TMO) | United States | $162.069B | 19.60 |
| Edwards Lifesciences (EW) | United States | $45.045B | 29.53 |
| IDEXX Laboratories (IDXX) | United States | $43.992B | 50.56 |
| Alcon (ALC) | Switzerland | $43.297B | 29.26 |
| DexCom (DXCM) | United States | $32.517B | 50.26 |
| IQVIA Holdings (IQV) | United States | $28.414B | 15.91 |
| Mettler-Toledo (MTD) | United States | $25.128B | 29.88 |
| STERIS (STE) | Ireland | $23.368B | 25.74 |
| Waters (WAT) | United States | $20.841B | 29.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.678B | 0.00 |
| Hologic (HOLX) | United States | $14.436B | 15.69 |
| Sysmex ADR (SSMXY) | Japan | $10.859B | 30.80 |
| Penumbra (PEN) | United States | $9.723B | 76.31 |
| Masimo (MASI) | United States | $9.086B | 33.51 |
| Globus Medical (GMED) | United States | $8.010B | 19.09 |
| Glaukos (GKOS) | United States | $5.914B | 0.00 |
| Teleflex (TFX) | United States | $5.298B | 8.75 |
| TransMedics (TMDX) | United States | $4.370B | 94.99 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| PROCEPT BioRobotics (PRCT) | United States | $3.205B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.515B | 14.98 |
| Nihon Kohden (NHNKY) | Japan | $2.346B | 26.90 |
| Veracyte (VCYT) | United States | $2.154B | 30.23 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.312B | 122.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.118B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.048B | 5.57 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| SiBone (SIBN) | United States | $0.787B | 0.00 |
| IRadimed (IRMD) | United States | $0.786B | 39.87 |
| Beta Bionics (BBNX) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.571B | 8.88 |
| Mesa Laboratories (MLAB) | United States | $0.564B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.546B | 0.00 |
| RxSight (RXST) | United States | $0.530B | 0.00 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.451B | 12.00 |
| Delcath Systems (DCTH) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.436B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.389B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.327B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Inogen (INGN) | United States | $0.201B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Accuray (ARAY) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.062B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.07 |